Nicholas A. Smith

Array ( [id] => 7423046 [patent_doc_number] => 20040265303 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Anti-CCR2 antibodies and methods of use therefor' [patent_app_type] => new [patent_app_number] => 10/826454 [patent_app_country] => US [patent_app_date] => 2004-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 18070 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20040265303.pdf [firstpage_image] =>[orig_patent_app_number] => 10826454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7123105 [patent_doc_number] => 20050014934 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-20 [patent_title] => 'Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis' [patent_app_type] => utility [patent_app_number] => 10/822300 [patent_app_country] => US [patent_app_date] => 2004-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 58 [patent_figures_cnt] => 58 [patent_no_of_words] => 40904 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20050014934.pdf [firstpage_image] =>[orig_patent_app_number] => 10822300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7181275 [patent_doc_number] => 20040202658 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-14 [patent_title] => 'Therapy of autoimmune disease in a patient with an inadequate response to TNF-alpha inhibitor' [patent_app_type] => new [patent_app_number] => 10/818765 [patent_app_country] => US [patent_app_date] => 2004-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17385 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20040202658.pdf [firstpage_image] =>[orig_patent_app_number] => 10818765 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5597078 [patent_doc_number] => 20060160996 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2006-07-20 [patent_title] => 'Optimized Fc variants and methods for their generation' [patent_app_type] => utility [patent_app_number] => 10/822231 [patent_app_country] => US [patent_app_date] => 2004-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 84804 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0160/20060160996.pdf [firstpage_image] =>[orig_patent_app_number] => 10822231 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5597078 [patent_doc_number] => 20060160996 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2006-07-20 [patent_title] => 'Optimized Fc variants and methods for their generation' [patent_app_type] => utility [patent_app_number] => 10/822231 [patent_app_country] => US [patent_app_date] => 2004-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 84804 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0160/20060160996.pdf [firstpage_image] =>[orig_patent_app_number] => 10822231 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 849279 [patent_doc_number] => 07381798 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-06-03 [patent_title] => 'Recombinant antibody recognizing dioxin and gene encoding the antibody' [patent_app_type] => utility [patent_app_number] => 10/550951 [patent_app_country] => US [patent_app_date] => 2004-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 14 [patent_no_of_words] => 9177 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/381/07381798.pdf [firstpage_image] =>[orig_patent_app_number] => 10550951 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7287039 [patent_doc_number] => 20040146980 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-29 [patent_title] => 'Isolated human lipase proteins, nucleic acid molecules encoding human lipase proteins, and uses thereof' [patent_app_type] => new [patent_app_number] => 10/802805 [patent_app_country] => US [patent_app_date] => 2004-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 19771 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20040146980.pdf [firstpage_image] =>[orig_patent_app_number] => 10802805 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7322122 [patent_doc_number] => 20040136908 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Anti-cd19 immunotoxins' [patent_app_type] => new [patent_app_number] => 10/474469 [patent_app_country] => US [patent_app_date] => 2004-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11361 [patent_no_of_claims] => 115 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20040136908.pdf [firstpage_image] =>[orig_patent_app_number] => 10474469 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4516199 [patent_doc_number] => 07932357 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-26 [patent_title] => 'FDF-03 S1 antigen-antibody complex' [patent_app_type] => utility [patent_app_number] => 10/780043 [patent_app_country] => US [patent_app_date] => 2004-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9120 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/932/07932357.pdf [firstpage_image] =>[orig_patent_app_number] => 10780043 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7308951 [patent_doc_number] => 20040142445 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-22 [patent_title] => 'Novel metalloprotease having aggrecanase activity' [patent_app_type] => new [patent_app_number] => 10/763210 [patent_app_country] => US [patent_app_date] => 2004-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15708 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20040142445.pdf [firstpage_image] =>[orig_patent_app_number] => 10763210 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7285842 [patent_doc_number] => 20040146505 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-29 [patent_title] => 'Substances' [patent_app_type] => new [patent_app_number] => 10/470045 [patent_app_country] => US [patent_app_date] => 2004-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 16376 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20040146505.pdf [firstpage_image] =>[orig_patent_app_number] => 10470045 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 809629 [patent_doc_number] => 07416727 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-08-26 [patent_title] => 'Polypeptide variants with altered effector function' [patent_app_type] => utility [patent_app_number] => 10/757863 [patent_app_country] => US [patent_app_date] => 2004-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 30 [patent_no_of_words] => 40271 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/416/07416727.pdf [firstpage_image] =>[orig_patent_app_number] => 10757863 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7305888 [patent_doc_number] => 20040116344 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Immunomodulatory properties of bip' [patent_app_type] => new [patent_app_number] => 10/471572 [patent_app_country] => US [patent_app_date] => 2004-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 7477 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20040116344.pdf [firstpage_image] =>[orig_patent_app_number] => 10471572 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 880450 [patent_doc_number] => 07355008 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-08 [patent_title] => 'Identification and engineering of antibodies with variant Fc regions and methods of using same' [patent_app_type] => utility [patent_app_number] => 10/754922 [patent_app_country] => US [patent_app_date] => 2004-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 75 [patent_no_of_words] => 78700 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/355/07355008.pdf [firstpage_image] =>[orig_patent_app_number] => 10754922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7418971 [patent_doc_number] => 20040228849 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => 'IKB kinase, subunits thereof, and methods of using same' [patent_app_type] => new [patent_app_number] => 10/739821 [patent_app_country] => US [patent_app_date] => 2003-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 24529 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20040228849.pdf [firstpage_image] =>[orig_patent_app_number] => 10739821 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7307417 [patent_doc_number] => 20040141973 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-22 [patent_title] => 'IPG antagonists for the treatment of conditions involving mast cells, basophils and eosinophils' [patent_app_type] => new [patent_app_number] => 10/735434 [patent_app_country] => US [patent_app_date] => 2003-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6888 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0141/20040141973.pdf [firstpage_image] =>[orig_patent_app_number] => 10735434 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7033605 [patent_doc_number] => 20050032114 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis' [patent_app_type] => utility [patent_app_number] => 10/687118 [patent_app_country] => US [patent_app_date] => 2003-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 34816 [patent_no_of_claims] => 69 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20050032114.pdf [firstpage_image] =>[orig_patent_app_number] => 10687118 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7181234 [patent_doc_number] => 20040202653 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-14 [patent_title] => 'Peptide-based passive immunization therapy for treatment of atherosclerosis' [patent_app_type] => new [patent_app_number] => 10/679032 [patent_app_country] => US [patent_app_date] => 2003-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 9345 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 41 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20040202653.pdf [firstpage_image] =>[orig_patent_app_number] => 10679032 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7250326 [patent_doc_number] => 20050074453 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-07 [patent_title] => 'Methods of preventing adhesions following laminectomies and other surgical procedures' [patent_app_type] => utility [patent_app_number] => 10/678011 [patent_app_country] => US [patent_app_date] => 2003-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1464 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20050074453.pdf [firstpage_image] =>[orig_patent_app_number] => 10678011 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7334818 [patent_doc_number] => 20040132101 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Optimized Fc variants and methods for their generation' [patent_app_type] => new [patent_app_number] => 10/672280 [patent_app_country] => US [patent_app_date] => 2003-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 70272 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20040132101.pdf [firstpage_image] =>[orig_patent_app_number] => 10672280 [rel_patent_id] =>[rel_patent_doc_number] =>)